TABLE 1.
Tabulation of the otherwise healthy vestibular schwannoma (VS) cases presenting with vertigo as the primary presenting symptom
Patient Number | Age | Sex | Diagno | Maximum Tumor sis Dimension (mm) | Pretreatment Dizziness Duration | Pretreatment Weekly Vertigo Frequency | Pretreatment Vertigo Duration | Medication Used for Resolution of Vertigo | Time to Resolution After Initiating Treatment | Eventual VS Treatment | Follow-up Duration (Mo) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 73 | F | VM | 12 mm | 7 years | 7 | 0.25–2 hours | Nortriptyline 50 mg | 2 months | Continued observation | 9 |
2 | 74 | F | BPV | 1.9 mm | 3 years | 7 | < 1 minute | Verapamil 120 mg | 1 week | CyberKnife radiation therapy | 36 |
3 | 71 | F | VM | 2.5 mm | 3 years | 5 | 1 hour | Nortriptyline 75 mg | 9 weeks | Continued observation | 11 |
4 | 47 | F | VM | 10 mm | 2 years | 7 | <1 minute | Nortriptyline 75mg | 9 months | Continued observation | 5 |
5 | 78 | F | VM | 13 mm | 3 years | 2 | 0.5 hours | Topiramate 25 mg | 3 months | Continued observation | 14 |
6 | 62 | M | VM | 14 mm | 2 years | 3 | 1–2 hours | Nortriptyline 10 | 3 weeks | CyberKnife radiation therapy | 18 |
7 | 51 | M | BPV | 20 mm | 3 week | 7 | < 1 minute | Epley maneuver | 1 week | Continued observation | 24 |
8 | 41 | F | VM | 10 mm | 2.5 years | 2 | 1 hour | Verapamil 240 mg | 3 months | Continued observation | 34 |
9 | 63 | F | VM | 11 mm | 1 year | 4 | 2 hours | Topiramate 150 mg | 2 months | Continued observation | 22 |
BPV indicates benign positional vertigo; VM, vestibular migraine.